BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12641861)

  • 1. Economic costs of influenza-related work absenteeism.
    Akazawa M; Sindelar JL; Paltiel AD
    Value Health; 2003; 6(2):107-15. PubMed ID: 12641861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden and absenteeism from influenza-like illness in healthy households with children (5-17 years) in the US.
    Li S; Leader S
    Respir Med; 2007 Jun; 101(6):1244-50. PubMed ID: 17156991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
    Burckel E; Ashraf T; de Sousa Filho JP; Forleo Neto E; Guarino H; Yauti C; Barreto F de B; Champion L
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):563-76. PubMed ID: 10662481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine for healthy adult workers: an issue for health authorities or employers?
    Garattini L; Koleva D
    Health Policy; 2011 Sep; 102(1):89-95. PubMed ID: 21093952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the influenza vaccine in a healthy, working-age population.
    Campbell DS; Rumley MH
    J Occup Environ Med; 1997 May; 39(5):408-14. PubMed ID: 9172085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study.
    Palmer LA; Rousculp MD; Johnston SS; Mahadevia PJ; Nichol KL
    Vaccine; 2010 Jul; 28(31):5049-56. PubMed ID: 20493819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective.
    Morales A; Martinez MM; Tasset-Tisseau A; Rey E; Baron-Papillon F; Follet A
    Value Health; 2004; 7(4):433-41. PubMed ID: 15449635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worksite influenza immunization programs. Insight into the implementation and cost-benefit.
    Olsen GW; Steinberg ME; Ley CA
    AAOHN J; 2005 Mar; 53(3):105-10. PubMed ID: 15789965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.
    Ferro A; Bordin P; Benacchio L; Fornasiero F; Bressan V; Tralli V; Moretti F; Majori S
    Ann Ig; 2020; 32(3):234-244. PubMed ID: 32266361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination in healthy working adults in Russia: observational study of effectiveness and return on investment for the employer.
    At'kov OY; Azarov AV; Zhukov DA; Nicoloyannis N; Durand L
    Appl Health Econ Health Policy; 2011 Mar; 9(2):89-99. PubMed ID: 21332253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
    Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
    Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance].
    Hak E; Knol LM; Wilschut JC; Postma MJ
    Ned Tijdschr Geneeskd; 2010; 154():A1188. PubMed ID: 20977784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.
    Nichol KL; D'Heilly SJ; Greenberg ME; Ehlinger E
    Clin Infect Dis; 2009 Feb; 48(3):292-8. PubMed ID: 19115970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.
    Nichol KL; Mallon KP; Mendelman PM
    Vaccine; 2003 May; 21(17-18):2207-17. PubMed ID: 12706712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of influenza vaccination on civilian aircrew illness and absenteeism.
    Mixéu MA; Vespa GN; Forleo-Neto E; Toniolo-Neto J; Alves PM
    Aviat Space Environ Med; 2002 Sep; 73(9):876-80. PubMed ID: 12234038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workplace vaccination against influenza in Malaysia: does the employer benefit?
    Samad AH; Usul MH; Zakaria D; Ismail R; Tasset-Tisseau A; Baron-Papillon F; Follet A
    J Occup Health; 2006 Jan; 48(1):1-10. PubMed ID: 16484757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.